Smallpox vaccine approved for monkeypox prevention
The European Medicines Agency (EMA) has recommended extending the use of Imvanex, a smallpox vaccine, for the prevention of monkeypox infection in adults. The news came as the… read more.
The European Medicines Agency (EMA) has recommended extending the use of Imvanex, a smallpox vaccine, for the prevention of monkeypox infection in adults. The news came as the… read more.
Scientists have worried since the outbreak of the Covid-19 pandemic that the virus, and the societal response to the outbreak, could have knock-on effects on health. One of… read more.
Researchers have identified a gene that promotes muscle strength when switched on by physical activity, unlocking the potential for the development of therapeutic treatments to mimic some of… read more.
People who suffer long-term consequences of Covid-19 can experience a wide range of symptoms. As the precise nature and duration of Long Covid is still being untangled by… read more.
Vaccination for COVID-19 does not appear to increase the risk of heart attack or stroke in patients with established cardiovascular disease, researchers reported on June 23, 2022 in Cardiovascular… read more.
Preliminary evidence shows potential for a fully-automated, online behavioral obesity treatment program to serve as a pragmatic resource in the primary care setting, according to a new study… read more.
Researchers report that a therapeutic “step strategy,” in which patients with diabetic macular edema begin their treatment with a less expensive drug and, if vision fails to improve,… read more.
New research in people with a cluster of heart disease risk factors has shown that consuming green tea extract for four weeks can reduce blood sugar levels and… read more.
Treatment advances have improved the survival of individuals with Hodgkin lymphoma (HL)—a type of cancer that affects the lymphatic system—but therapies can increase patients’ risk of developing heart… read more.
Mycobacterium tuberculosis, the causative agent of tuberculosis, remains the leading cause of infectious disease worldwide, affecting approximately a quarter of the globe’s population. Treatment of infections is problematic… read more.
Patients are 20% less likely to die of sepsis because a new AI system developed at Johns Hopkins University catches symptoms hours earlier than traditional methods, an extensive… read more.
People who supplement rescue inhalers with a second asthma medication sometimes get little relief at first, but there’s good news: Those who keep trying different options often find… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.